U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes
Diabetes Technology and Therapeutics- United States
doi 10.1089/dia.2011.0248
Full Text
Abstract
Available in
Date
June 1, 2012
Authors
Publisher
Mary Ann Liebert Inc
doi 10.1089/dia.2011.0248
Available in
June 1, 2012
Mary Ann Liebert Inc